Senti Biosciences, Inc. (NASDAQ:SNTI – Get Free Report)’s share price dropped 8.7% during trading on Monday . The company traded as low as $0.27 and last traded at $0.28. Approximately 91,570 shares traded hands during trading, a decline of 16% from the average daily volume of 108,970 shares. The stock had previously closed at $0.31.
Senti Biosciences Stock Down 8.7 %
The stock has a market cap of $12.85 million, a PE ratio of -0.18 and a beta of 2.96. The stock has a 50-day moving average of $0.39 and a 200 day moving average of $0.41.
Senti Biosciences (NASDAQ:SNTI – Get Free Report) last announced its quarterly earnings data on Thursday, March 21st. The company reported ($0.42) EPS for the quarter. Senti Biosciences had a negative return on equity of 74.59% and a negative net margin of 2,692.82%. Research analysts forecast that Senti Biosciences, Inc. will post -1 EPS for the current fiscal year.
Institutional Investors Weigh In On Senti Biosciences
About Senti Biosciences
Senti Biosciences, Inc operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications.
Featured Articles
- Five stocks we like better than Senti Biosciences
- How to Use Stock Screeners to Find Stocks
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- The Significance of Brokerage Rankings in Stock Selection
- Merger or Not, Albertson’s Companies is a Good Buy
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Senti Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senti Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.